1. Home
  2. BTOC vs SNTI Comparison

BTOC vs SNTI Comparison

Compare BTOC & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.31

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.33

Market Cap

12.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
SNTI
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
12.1M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BTOC
SNTI
Price
$0.31
$0.33
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$2.00
$8.50
AVG Volume (30 Days)
34.8K
183.4K
Earning Date
05-24-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$0.33
52 Week High
$1.45
$2.88

Technical Indicators

Market Signals
Indicator
BTOC
SNTI
Relative Strength Index (RSI) 56.41 35.26
Support Level $0.25 $0.33
Resistance Level $0.32 $0.40
Average True Range (ATR) 0.02 0.04
MACD 0.00 0.01
Stochastic Oscillator 74.92 13.39

Price Performance

Historical Comparison
BTOC
SNTI

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: